“…Not all men with Gleason score 8-10 disease, however, are destined to experience BCR. When assessing risk of recurrence after RP, many studies consider pathological features, either individually, as pathological stage, or in various 'favourable' or 'unfavourable' groupings, as risk factors for BCR or other endpoints, such as prostate cancerspecific survival [5,[8][9][10][11][12][13][14][15][16][17], but while previous studies have examined the relationship between pathological features and BCR in pathological high grade disease [18,19], these studies are >10 years old and, to our knowledge, have not been updated to examine a more racially heterogeneous cohort of men. We therefore used the SEARCH database of men treated with RP [20] to identify men with pathological high grade disease (Gleason score [8][9][10] and to create groups based on various combinations of pathological features and compare these groups with regard to BCR risk.…”